A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-5817 Injection
Clinical trial NCT06934408 · RECRUITING
Trial details
- NCT number
- NCT06934408
- Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-08
- Primary completion
- 2027-04-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.